Overview

Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection

Status:
Terminated
Trial end date:
2017-08-14
Target enrollment:
Participant gender:
Summary
This study will evaluate the long term effects of hepatitis B virus (HBV) treatment on the HBV serologic changes and HBV DNA levels through Week 144. This registry will enroll only individuals who were treated in a Gilead-sponsored trial for chronic hepatitis B (CHB).
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Tenofovir
Vesatolimod